We're really mired in the low $4's, selling now at pre-TEVA pricing. If this is a free market response to ALXA partnering with TEVA and shedding the risk going forward of their patented and FDA approved inhalation technology, then we are missing something. I simply cannot believe this has languished without more investor interest. Will we discover there has been a massive manipulation at work to keep the share price down? Anything is possible. Try to look away longs, we've got to have a different set of facts as revenues start to flow, and the earnings get announced. Where are the upgrades, Roth?
